← Open Payments lookup

OMOTAYO GBENGAOJO: Open Payments

NPI 1972201895 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,428 in 42 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $669 · 2025 $1,428

Food & beverage: $1,428
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc7$320
ABBVIE INC.10$276
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$252
Supernus Pharmaceuticals, Inc.6$185
Otsuka America Pharmaceutical, Inc.3$145
Alkermes, Inc.1$119
Teva Pharmaceuticals USA, Inc.3$62
E.R. Squibb & Sons, L.L.C.1$23
Lundbeck LLC1$23
Axsome Therapeutics, Inc.1$22

Products named: INVEGA SUSTENNA, VRAYLAR, CAPLYTA, Qelbree, REXULTI, ARISTADA, UZEDY, COBENFY.

Industry payments across TX — which companies pay providers there.